Radha Vishwanathan is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as a Principal Consultant at PQE Group since March 2020, Radha previously held the position of Chief Technical Officer at Novitate Pharma Inc from August 2020 to August 2022. Prior experience includes roles such as Vice President at both Akorn, Inc (October 2012 - July 2018) and Fresenius Kabi (January 2011 - September 2012), as well as Director at Fresenius Kabi Oncology Ltd. (August 2008 - December 2010) and Associate Director at Dabur Research Foundation (August 1992 - July 2008). Radha's educational background includes a degree from Jamia Hamdard, completed between 1990 and 1992.